185 related articles for article (PubMed ID: 19168568)
1. Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.
Roebuck BD; Johnson DN; Sutter CH; Egner PA; Scholl PF; Friesen MD; Baumgartner KJ; Ware NM; Bodreddigari S; Groopman JD; Kensler TW; Sutter TR
Toxicol Sci; 2009 May; 109(1):41-9. PubMed ID: 19168568
[TBL] [Abstract][Full Text] [Related]
2. Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.
Bodreddigari S; Jones LK; Egner PA; Groopman JD; Sutter CH; Roebuck BD; Guengerich FP; Kensler TW; Sutter TR
Chem Res Toxicol; 2008 May; 21(5):1134-42. PubMed ID: 18416522
[TBL] [Abstract][Full Text] [Related]
3. Protection against aflatoxin B1 in rat--a new look at the link between toxicity, carcinogenicity, and metabolism.
Ellis EM
Toxicol Sci; 2009 May; 109(1):1-3. PubMed ID: 19293422
[No Abstract] [Full Text] [Related]
4. Quantification of urinary aflatoxin B1 dialdehyde metabolites formed by aflatoxin aldehyde reductase using isotope dilution tandem mass spectrometry.
Johnson DN; Egner PA; Obrian G; Glassbrook N; Roebuck BD; Sutter TR; Payne GA; Kensler TW; Groopman JD
Chem Res Toxicol; 2008 Mar; 21(3):752-60. PubMed ID: 18266327
[TBL] [Abstract][Full Text] [Related]
5. cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3.
Knight LP; Primiano T; Groopman JD; Kensler TW; Sutter TR
Carcinogenesis; 1999 Jul; 20(7):1215-23. PubMed ID: 10383892
[TBL] [Abstract][Full Text] [Related]
6. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
7. Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: implications for human biotransformation enzyme polymorphisms.
Eaton DL; Bammler TK; Kelly EJ
Adv Exp Med Biol; 2001; 500():559-76. PubMed ID: 11764998
[TBL] [Abstract][Full Text] [Related]
8. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
Kwak MK; Egner PA; Dolan PM; Ramos-Gomez M; Groopman JD; Itoh K; Yamamoto M; Kensler TW
Mutat Res; 2001 Sep; 480-481():305-15. PubMed ID: 11506823
[TBL] [Abstract][Full Text] [Related]
9. Protection conferred by selenium deficiency against aflatoxin B1 in the rat is associated with the hepatic expression of an aldo-keto reductase and a glutathione S-transferase subunit that metabolize the mycotoxin.
McLeod R; Ellis EM; Arthur JR; Neal GE; Judah DJ; Manson MM; Hayes JD
Cancer Res; 1997 Oct; 57(19):4257-66. PubMed ID: 9331086
[TBL] [Abstract][Full Text] [Related]
10. Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat.
Simonich MT; Egner PA; Roebuck BD; Orner GA; Jubert C; Pereira C; Groopman JD; Kensler TW; Dashwood RH; Williams DE; Bailey GS
Carcinogenesis; 2007 Jun; 28(6):1294-302. PubMed ID: 17290047
[TBL] [Abstract][Full Text] [Related]
11. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
Gross-Steinmeyer K; Eaton DL
Toxicology; 2012 Sep; 299(2-3):69-79. PubMed ID: 22640941
[TBL] [Abstract][Full Text] [Related]
12. Dissimilarity in aflatoxin dose-response relationships between DNA adduct formation and development of preneoplastic foci in rat liver.
Root M; Lange T; Campbell TC
Chem Biol Interact; 1997 Oct; 106(3):213-27. PubMed ID: 9413548
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of biliary excretion of aflatoxin B(1) and suppression of hepatic ornithine decarboxylase activity by 2-(allylthio)pyrazine in rats.
Ha TG; Mar WC; Kim SG; Surh YJ; Kim ND
Mutat Res; 1999 Jul; 428(1-2):59-67. PubMed ID: 10517979
[TBL] [Abstract][Full Text] [Related]
14. Trp266 determines the binding specificity of a porcine aflatoxin B₁ aldehyde reductase for aflatoxin B₁-dialdehyde.
Wu J; Xu W; Zhang C; Chang Q; Tang X; Li K; Deng Y
Biochem Pharmacol; 2013 Nov; 86(9):1357-65. PubMed ID: 24008121
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat.
Bedard LL; Alessi M; Davey S; Massey TE
Cancer Res; 2005 Feb; 65(4):1265-70. PubMed ID: 15735011
[TBL] [Abstract][Full Text] [Related]
16. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ebselen on aflatoxin B(1)-induced hepatocarcinogenesis in Fischer 344 rats.
Yang CF; Liu J; Wasser S; Shen HM; Tan CE; Ong CN
Carcinogenesis; 2000 Dec; 21(12):2237-43. PubMed ID: 11133813
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.
Kelly VP; Ellis EM; Manson MM; Chanas SA; Moffat GJ; McLeod R; Judah DJ; Neal GE; Hayes JD
Cancer Res; 2000 Feb; 60(4):957-69. PubMed ID: 10706111
[TBL] [Abstract][Full Text] [Related]
19. Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis).
Li Y; Su J; Qin L; Egner PA; Wang J; Groopman JD; Kensler TW; Roebuck BD
Cancer Lett; 2000 Jun; 154(1):79-83. PubMed ID: 10799742
[TBL] [Abstract][Full Text] [Related]
20. Effects of intermittent exposures of aflatoxin B(1) on hepatic and testicular glutathione S-transferase in rats.
Sahu SC; Chou MW; Sotomayor RE; Hinton DM; Barton CN; O'Donnell MW
J Appl Toxicol; 2000; 20(3):215-9. PubMed ID: 10797475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
